Skip to main content

Charles River Laboratories International Inc. (CRL) Stock

Charles River Laboratories International Inc. Stock Details, Movements and Public Alerts

Stock Details

Charles River Laboratories International Inc. (CRL), a prominent company in the trade & services sector within the services-commercial physical & biological research industry, is based in USA and primarily trades on the NYSE.Currently, the stock is trading at $159.40. Over the past 52 weeks, it has ranged between $91.86 and $254.15. This places the current price at 62.7% of its 52-week high and 73.5% above its 52-week low. Recent trading volume was recorded at 114,336. The International Securities Identification Number (ISIN) for this stock is US1598641074.

52-Week High

$254.15

-37.28% from high

52-Week Low

$91.86

+73.52% from low

Avg Daily Volume

114,336

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

15.70

PEG Ratio

0.13

Potentially undervalued

Price to Book

2.31

EV/EBITDA

18.54

EPS (TTM)

-$0.62

Price to Sales

1.83

Beta

1.48

Similar volatility to market

How is CRL valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is CRL's risk profile compared to the market?
With a beta of 1.48, Charles River Laboratories International Inc. is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 2.31 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

-0.49%

Operating Margin

13.60%

Return on Equity

-0.67%

Return on Assets

4.27%

Revenue Growth (YoY)

-2.70%

Earnings Growth (YoY)

-61.50%

How profitable and efficient is CRL's business model?
Charles River Laboratories International Inc. achieves a profit margin of -0.49%, meaning it retains $-0.49 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 13.60% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -0.67% and ROA at 4.27%, the company achieves moderate returns on invested capital.
What are CRL's recent growth trends?
Charles River Laboratories International Inc.'s revenue declined by 2.70% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions. Earnings decreased by 61.50% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry averages for proper context.

Company Size & Market

Market Cap

$7.37B

Shares Outstanding

49.12M

Book Value/Share

$65.04

Asset Type

Common Stock

What is CRL's market capitalization and position?
Charles River Laboratories International Inc. has a market capitalization of $7.37B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 49.12M shares outstanding, the company's ownership is relatively concentrated. As a participant in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry, it competes with other firms in this sector.
How does CRL's price compare to its book value?
Charles River Laboratories International Inc.'s book value per share is $65.04, while the current stock price is $159.40, resulting in a price-to-book (P/B) ratio of 2.45. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$156.14

2.05% downside potential

Analyst Recommendations

Strong Buy

1

Buy

4

Hold

14

Sell

1

Strong Sell

0

How reliable are analyst predictions for CRL?
20 analysts cover CRL with 25% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The bearish sentiment could create opportunity if analysts are wrong. The consensus target of $156.14 implies -2.0% downside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on CRL?
Current analyst recommendations:1 Strong Buy, 4 Buy, 14 Hold, 1 Sell, 0The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Jul 1, 2025, 02:04 AM

Technical Indicators

What does CRL's RSI value tell investors?
RSI data is not available for this stock.
How should traders interpret CRL's MACD and moving average crossovers?
MACD and moving average data are not available for this stock.

No technical indicators available yet.

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for CRL and get notified when the price changes.

Stay Ahead of the Market with Charles River Laboratories International Inc. Alerts

Set up price alerts for Charles River Laboratories International Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.